Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Current Leases (2021 - 2025)

Historic Current Leases for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $7.7 million.

  • Prime Medicine's Current Leases rose 7203.39% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 7203.39%. This contributed to the annual value of $3.6 million for FY2024, which is 6103.92% down from last year.
  • Per Prime Medicine's latest filing, its Current Leases stood at $7.7 million for Q3 2025, which was up 7203.39% from $7.3 million recorded in Q2 2025.
  • Prime Medicine's 5-year Current Leases high stood at $13.5 million for Q2 2023, and its period low was $3.6 million during Q4 2024.
  • Its 5-year average for Current Leases is $8.4 million, with a median of $7.5 million in 2021.
  • Per our database at Business Quant, Prime Medicine's Current Leases tumbled by 6138.87% in 2024 and then soared by 7203.39% in 2025.
  • Quarter analysis of 5 years shows Prime Medicine's Current Leases stood at $7.3 million in 2021, then soared by 59.41% to $11.7 million in 2022, then decreased by 20.68% to $9.3 million in 2023, then plummeted by 61.04% to $3.6 million in 2024, then surged by 113.45% to $7.7 million in 2025.
  • Its last three reported values are $7.7 million in Q3 2025, $7.3 million for Q2 2025, and $6.9 million during Q1 2025.